{"entities":{"Q100711":{"pageid":102030,"ns":120,"title":"Item:Q100711","lastrevid":84645023,"modified":"2026-05-28T08:23:00Z","type":"item","id":"Q100711","labels":{"en":{"language":"en","value":"A robust Bayesian dose-finding design for phase I/II clinical trials"}},"descriptions":{"en":{"language":"en","value":"scientific article"}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"fd5912e4dab4b881a8eb0eb27e7893fef55176ad","datavalue":{"value":{"entity-type":"item","numeric-id":56887,"id":"Q56887"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q100711$3A0A3FB2-54AA-443A-9F99-8B8D01C45A7B","rank":"normal"}],"P200":[{"mainsnak":{"snaktype":"value","property":"P200","hash":"19858256f499635f7a4e8c9f6dad0bd1d83e3321","datavalue":{"value":{"entity-type":"item","numeric-id":63386,"id":"Q63386"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q100711$5396EC8E-6F1A-422F-9423-93EF594EC78D","rank":"normal"}],"P26":[{"mainsnak":{"snaktype":"value","property":"P26","hash":"4643af52b962cd2b49dc158b21805c28ed717b8c","datavalue":{"value":"17","type":"string"},"datatype":"string"},"type":"statement","id":"Q100711$F2501A25-5FB5-482B-BA5B-2D28444BFC70","rank":"normal"}],"P25":[{"mainsnak":{"snaktype":"value","property":"P25","hash":"b8f23e21c54d542f784defaef10454ba7971b38a","datavalue":{"value":"2","type":"string"},"datatype":"string"},"type":"statement","id":"Q100711$E000DB10-185C-4324-82FB-C66A0C50DA77","rank":"normal"}],"P128":[{"mainsnak":{"snaktype":"value","property":"P128","hash":"a288b4e3b64f42dfc3e85157b931018b8b5e9404","datavalue":{"value":"249-263","type":"string"},"datatype":"string"},"type":"statement","id":"Q100711$ADFB2472-DEBC-442A-904E-DD2579B0AF21","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"0ca124807d665f1ac71f73d3aada45c27dfaabea","datavalue":{"value":{"time":"+2015-10-20T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q100711$4CD5190D-E620-42C0-8D39-1B202EA848B0","rank":"normal"}],"P12":[{"mainsnak":{"snaktype":"value","property":"P12","hash":"ee36ef8d71ac4eabafdca2c23d5c44716a80c7d0","datavalue":{"value":"Q37220245","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q100711$31E3DD9C-943E-4591-97BC-F3DDA2658B3D","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"57f7fea50d2ce1b39b695c4a1313582eed405e38","datavalue":{"value":{"entity-type":"item","numeric-id":5976449,"id":"Q5976449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q100711$614CCFAE-A08C-4840-B13F-70BEE1FE554A","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"39e60b63251f98db12106d65a44dd67f6e0234c7","datavalue":{"value":"10.1093/BIOSTATISTICS/KXV040","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q100711$8939C46C-74F3-4A17-B7DE-76F03E56255B","rank":"normal"}],"P43":[{"mainsnak":{"snaktype":"value","property":"P43","hash":"ec43c7efc846e1a6296811d3f48fb83879b8a090","datavalue":{"value":"Suyu Liu","type":"string"},"datatype":"string"},"type":"statement","id":"Q100711$2E33B548-FDD1-466C-B70A-CB8EBB95E82C","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"c0e8be0bd2d8884784cebe433fd9af4ed29f27a0","datavalue":{"value":"Valen E. Johnson","type":"string"},"datatype":"string"},"type":"statement","id":"Q100711$B087F597-51D0-4956-A041-F8E96DC2AE46","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"A robust Bayesian dose-finding design for phase I/II clinical trials","badges":[],"url":"https://portal.mardi4nfdi.de/wiki/A_robust_Bayesian_dose-finding_design_for_phase_I/II_clinical_trials"}}}}}